These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30192655)

  • 1. A pilot clinical trial of a near-infrared laser vaccine adjuvant: safety, tolerability, and cutaneous immune cell trafficking.
    Gelfand JA; Nazarian RM; Kashiwagi S; Brauns T; Martin B; Kimizuka Y; Korek S; Botvinick E; Elkins K; Thomas L; Locascio J; Parry B; Kelly KM; Poznansky MC
    FASEB J; 2019 Feb; 33(2):3074-3081. PubMed ID: 30192655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.
    Morse K; Kimizuka Y; Chan MPK; Shibata M; Shimaoka Y; Takeuchi S; Forbes B; Nirschl C; Li B; Zeng Y; Bronson RT; Katagiri W; Shigeta A; Sîrbulescu RF; Chen H; Tan RYY; Tsukada K; Brauns T; Gelfand J; Sluder A; Locascio JJ; Poznansky MC; Anandasabapathy N; Kashiwagi S
    J Immunol; 2017 Aug; 199(4):1319-1332. PubMed ID: 28710250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser vaccine adjuvant for cutaneous immunization.
    Chen X; Wu MX
    Expert Rev Vaccines; 2011 Oct; 10(10):1397-403. PubMed ID: 21988305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser vaccine adjuvants. History, progress, and potential.
    Kashiwagi S; Brauns T; Gelfand J; Poznansky MC
    Hum Vaccin Immunother; 2014; 10(7):1892-907. PubMed ID: 25424797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.
    Kimizuka Y; Katagiri W; Locascio JJ; Shigeta A; Sasaki Y; Shibata M; Morse K; Sîrbulescu RF; Miyatake M; Reeves P; Suematsu M; Gelfand J; Brauns T; Poznansky MC; Tsukada K; Kashiwagi S
    J Immunol; 2018 Dec; 201(12):3587-3603. PubMed ID: 30420435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared laser adjuvant for influenza vaccine.
    Kashiwagi S; Yuan J; Forbes B; Hibert ML; Lee EL; Whicher L; Goudie C; Yang Y; Chen T; Edelblute B; Collette B; Edington L; Trussler J; Nezivar J; Leblanc P; Bronson R; Tsukada K; Suematsu M; Dover J; Brauns T; Gelfand J; Poznansky MC
    PLoS One; 2013; 8(12):e82899. PubMed ID: 24349390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.
    Meneveau MO; Petroni GR; Salerno EP; Lynch KT; Smolkin M; Woodson E; Chianese-Bullock KA; Olson WC; Deacon D; Patterson JW; Grosh WW; Slingluff CL
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34035112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment.
    Pollack KE; Meneveau MO; Melssen MM; Lynch KT; Koeppel AF; Young SJ; Turner S; Kumar P; Sol-Church K; Mauldin IS; Slingluff CL
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32350119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-fractional epidermal powder delivery for improved skin vaccination.
    Chen X; Kositratna G; Zhou C; Manstein D; Wu MX
    J Control Release; 2014 Oct; 192():310-6. PubMed ID: 25135790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants in cutaneous vaccination: A comprehensive analysis.
    Oladejo M; Tijani AO; Puri A; Chablani L
    J Control Release; 2024 May; 369():475-492. PubMed ID: 38569943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response.
    Rüttinger D; van den Engel NK; Winter H; Schlemmer M; Pohla H; Grützner S; Wagner B; Schendel DJ; Fox BA; Jauch KW; Hatz RA
    J Transl Med; 2007 Sep; 5():43. PubMed ID: 17868452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous and intradermal vaccination.
    Combadiere B; Liard C
    Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective and Safe Stimulation of Humoral and Cell-Mediated Immunity by Intradermal Immunization with a Cyclic Dinucleotide/Nanoparticle Combination Adjuvant.
    Hernandez-Franco JF; Mosley YC; Franco J; Ragland D; Yao Y; HogenEsch H
    J Immunol; 2021 Feb; 206(4):700-711. PubMed ID: 33380496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass vaccination: solutions in the skin.
    Glenn GM; Kenney RT
    Curr Top Microbiol Immunol; 2006; 304():247-68. PubMed ID: 16989274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser-assisted epicutaneous immunization to target human skin dendritic cells.
    Tripp CH; Voit H; An A; Seidl-Philipp M; Krapf J; Sigl S; Romani N; Del Frari B; Stoitzner P
    Exp Dermatol; 2021 Sep; 30(9):1279-1289. PubMed ID: 33797121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
    Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
    Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design.
    Teunissen MB; Haniffa M; Collin MP
    Curr Top Microbiol Immunol; 2012; 351():25-76. PubMed ID: 21833835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.
    Antonio-Herrera L; Badillo-Godinez O; Medina-Contreras O; Tepale-Segura A; García-Lozano A; Gutierrez-Xicotencatl L; Soldevila G; Esquivel-Guadarrama FR; Idoyaga J; Bonifaz LC
    Front Immunol; 2018; 9():2212. PubMed ID: 30319653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel laser vaccine adjuvant increases the motility of antigen presenting cells.
    Chen X; Kim P; Farinelli B; Doukas A; Yun SH; Gelfand JA; Anderson RR; Wu MX
    PLoS One; 2010 Oct; 5(10):e13776. PubMed ID: 21048884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.